ResMed (RMD) Reports In-Line Q1 EPS, Beats on Revenues
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $222.52 +0.25%
EPS Growth %: +5.5%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +5.5%
Financial Fact:
Income taxes (note 13): 16.82M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.66, in-line with the analyst estimate of $0.66. Revenue for the quarter came in at $523.7 million versus the consensus estimate of $505.61 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- AppLovin drops 3% as Edgewater analyst warns of stalled market share growth
- KeyBanc Sees 'A Potential Catalyst for Earnings Growth and Value Creation' for Acadia Realty Trust (AKR)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
